US 11266641
Formulations of a somatostatin modulator
granted A61KA61K31/4709A61K45/06
Quick answer
US patent 11266641 (Formulations of a somatostatin modulator) held by CRINETICS PHARMACEUTICALS, INC. expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRINETICS PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/4709, A61K45/06, A61K9/0053, A61K9/1611